BIOT Stock Overview
Bioter S.A. operates as a technical construction company in Greece and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bioter S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.27 |
| 52 Week High | €0.44 |
| 52 Week Low | €0.20 |
| Beta | 0.46 |
| 1 Month Change | -21.71% |
| 3 Month Change | 30.48% |
| 1 Year Change | 16.10% |
| 3 Year Change | -33.17% |
| 5 Year Change | 453.54% |
| Change since IPO | -98.79% |
Recent News & Updates
Shareholder Returns
| BIOT | GR Construction | GR Market | |
|---|---|---|---|
| 7D | 0% | 1.2% | 3.7% |
| 1Y | 16.1% | 54.2% | 28.5% |
Price Volatility
| BIOT volatility | |
|---|---|
| BIOT Average Weekly Movement | 12.2% |
| Construction Industry Average Movement | 4.6% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in GR Market | 8.0% |
| 10% least volatile stocks in GR Market | 2.4% |
Volatility Over Time: BIOT's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Greek stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 4 | Ioannis Konstantinopoulos | www.bioter.gr |
Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various large public and private projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects comprising offices, banks, bus stations, etc. Bioter S.A. was founded in 1961 and is headquartered in Athens, Greece.
Bioter S.A. Fundamentals Summary
| BIOT fundamental statistics | |
|---|---|
| Market cap | €4.58m |
| Earnings (TTM) | -€9.49m |
| Revenue (TTM) | €471.00k |
9.7x
P/S Ratio-0.5x
P/E RatioIs BIOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOT income statement (TTM) | |
|---|---|
| Revenue | €471.00k |
| Cost of Revenue | -€433.00k |
| Gross Profit | €904.00k |
| Other Expenses | €10.40m |
| Earnings | -€9.49m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.57 |
| Gross Margin | 191.93% |
| Net Profit Margin | -2,015.07% |
| Debt/Equity Ratio | -158.2% |
How did BIOT perform over the long term?
See historical performance and comparison